PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290850
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290850
MiRNA Tools and Services Market size was valued at USD 380.7 million in 2022, expanding at a CAGR of 20.5% from 2023 to 2030.
miRNA (microRNA) tools and services are resources and solutions specifically designed for studying and analyzing microRNAs, small non-coding RNA molecules that play important regulatory roles in gene expression. MicroRNAs (miRNAs) are a series of promising molecules that could regulate gene expression, while their expression level and type are strictly related to the early diagnosis, targeted therapy, and prognosis of diseases. Improved detection accuracy of miRNAs would lead to unprecedented progress in early treatment. Numerous methods to improve sensitivity have been proposed and confirmed valuable in miRNA detection recently. There are several platforms, such as microarrays and next-generation sequencing (NGS), are available for miRNA expression profiling. These technologies enable researchers to analyze miRNA expression patterns in different samples and conditions.
The increasing number of clinical trials focused on chronic illnesses is expected to drive the demand for miRNA tools and services. MicroRNAs (miRNAs) have gained significant attention in recent years due to their potential as biomarkers and therapeutic targets for various chronic diseases. National Center for biotechnology information, Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. At the same time, those with multimorbidity are projected to increase 91.16% from 7.8304 million in 2020 to 14.968 million in 2050.
The Global MiRNA Tools and Services Market is segmented on the basis of Technology, Application, and Region.
The market is divided into three categories based on Technology: qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools, and Others. qRT-PCR segment dominates the market growth, due to the commonly used technique for miRNA quantification and validation is quantitative reverse transcription-polymerase chain reaction (qRT-PCR).
The market is divided into two categories based on application: Research & Academic Institutes, IVD, Pharma & Biotech Companies, and CROs. IVD, Pharma & Biotech Companies sector dominates the market and is likely to maintain its dominance during the forecast period. MiRNA tools and services are utilized by various industries, including in vitro diagnostics (IVD), pharmaceutical, and biotechnology companies, for a range of applications.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Asia Pacific is expected to dominate the growth of the miRNA Tools and Services Market, due to the increase in cardiovascular disease and cancer incidences. Abnormal patterns of hematopoietic-specific miRNAs have been found in different types of cancer and miRNA-based gene therapy is being considered a potential technology of choice in immunological disorders and cancer. According to the national center for biotechnology information, in 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all deaths in rural and urban areas, respectively. Two out of every five deaths were due to CVD. It is estimated that about 330 million patients suffer from CVD in China. Overall, the miRNA Tools and Services market is expected to experience significant growth in all regions.
miRNA (microRNA) tools and services are widely available for researchers studying miRNAs and their functions. These tools and services encompass various aspects, including miRNA isolation, analysis, profiling, functional studies, and more. The field of miRNA tools and services is highly competitive with both established companies and emerging players offering innovative solutions. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in 2022, Predictive models using serum miRNAs may offer objective criteria for referral to early palliative care services
On 31 March 2022, Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, nowadays announced the publication of a study in the journal npj Precision Oncology that describes the discovery and validation of miRisk, a first-of-its-kind microRNA (miRNA) biomarker signature that offers the prospect of a blood-based companion diagnostic for immunotherapy in advanced non-small cell lung cancer (NSCLC).
The scope of this report covers the market by its major segments, which include as follows: